Evidence map›Paper›PMID 40475763›Full record

ArticleFrontiers in immunology2025

TIM3 and TIGIT-expressing CD4 T cells are impacted by kidney transplantation and associated with risk of infection.

Harry Pickering, Subha Sen, Monica Cappelletti, Erik L Lum, Suphamai Bunnapradist, Elaine F Reed, Joanna M Schaenman

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Harry PickeringDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, United States.
Subha SenDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, United States.
Monica CappellettiDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, United States.
Erik L LumDivision of Nephrology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, United States.
Suphamai BunnapradistDivision of Nephrology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, United States.
Elaine F ReedDepartment of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, United States.
Joanna M SchaenmanDivision of Infectious Diseases, Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, United States.

Funding

Project 3: Mapping the Evolution of Chronic Transplant Injury in the Context of CMV InfectionU19AI128913 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI REED, ELAINE F, SARWAL, MINNIE M · 2017 to 2021
$11.2M
Systems analyses of induction and maintenance of immunity to SARS-CoV-2 vaccination in kidney transplant recipients receiving mycophenolate mofetil immunotherapyU01AI179524 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ELAINE F REED · 2024 to 2026
$1.9M
Evaluation of Epigenetic Markers of Biologic Age to Predict Adverse Outcomes after TransplantationR21AG055879 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SCHAENMAN, JOANNA M · 2018 to 2019
$429k
Evaluation of T Cell Immune Function Impairment in Elderly Solid Organ Transplant RecipientsR03AG050946 · NIA · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SCHAENMAN, JOANNA M · 2015 to 2016
$231k
NIAID NIH HHS U01 AI179524NIAID NIH HHS U19 AI128913NIA NIH HHS R03 AG050946NIA NIH HHS R21 AG055879
6 · The paper itself

Abstract

Introduction: Older kidney transplant patients experience higher rates of infection compared with younger transplant patients suggesting the impact of age-associated immune dysfunction. However, little is known about the impact of immunosuppression including antithymocyte globulin (ATG) induction, as well as whether T cell subtypes can predict risk for infection. Methods: We collected blood from 91 patients before and then 3 months after kidney transplantation and analyzed CD4 and CD8 T cell phenotypes to determine the impact of immunosuppression on immune maturation, senescence, and infection. Results: After transplantation the number of naïve T cells decreased overall, while TIM3-expressing naïve and central memory (CM) CD4 T cell frequency increased, with more striking change in patients receiving ATG compared with basiliximab induction. Transplantation also led to increased frequency of TIGIT-expressing effector memory (EM) CD4 T cells and senescent TIGIT and KLRG1-expressing CD8 T cells. Decreased frequencies of naïve CD4 and CD8 T cells (p=0.016 and p=0.038, respectively) and increased frequency of CD4 CM and EM TIGIT+ T cells (p=0.022) were associated with development of infection. A model incorporating increased frequency CD4 EM TIGIT+ T cells and ATG induction was predictive of development of infection after kidney transplantation (HR 3.73, CI 1.08-12.9). Discussion: Increased frequency of TIM3 and TIGIT markers associated with T cell experience and senescence was a notable phenotypic change associated with transplantation and induction and maintenance immunosuppression. Incorporation of TIGIT expression and induction type into an infection prediction model holds promise for risk stratification and individualization of immunosuppression to decrease risk of adverse outcomes, especially for older patients.

Indexed as

CD4-Positive T-LymphocytesHepatitis A Virus Cellular Receptor 2InfectionsKidney TransplantationReceptors, ImmunologicAdultAgedCD8-Positive T-LymphocytesFemaleHumansImmunosuppressive AgentsMaleMiddle AgedHAVCR2 protein, humanHepatitis A Virus Cellular Receptor 2Immunosuppressive AgentsReceptors, ImmunologicTIGIT protein, humanantithymocyte globulinimmunosuppressioninfectionkidney transplantationT cell

Identifiers

PMID40475763
PMCPMC12137242

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.